首页> 美国卫生研究院文献>Canadian Urological Association Journal >Double jeopardy? Renal-sparing management of simultaneous ipsilateral renal cell carcinoma and urothelial carcinoma
【2h】

Double jeopardy? Renal-sparing management of simultaneous ipsilateral renal cell carcinoma and urothelial carcinoma

机译:双重危险?同时患侧肾细胞癌和尿路上皮癌的保肾治疗

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The occurrence of renal cell carcinoma (RCC) and urothelial carcinoma (UC) synchronously in the same kidney is exceedingly rare. All reported cases have been managed with either nephroureterectomy or nephrectomy. We report on a patient who required renal-sparing management of his double malignancy, including open partial nephrectomy of his pT1a RCC and endoscopic laser ablation of his low-grade Ta renal pelvis UC. After 4 years, the patient is in good health and disease-free under strict surveillance. It, therefore, would appear justified to combine partial nephrectomy for RCC and endoscopic management of UC in the same kidney of an appropriately selected patient.
机译:在同一肾脏中同时发生肾细胞癌(RCC)和尿路上皮癌(UC)的情况极为罕见。所有报告的病例均接受了肾结直肠切除术或肾切除术治疗。我们报道了一名患者,该患者需要保留双恶性肿瘤的肾脏,包括对其pT1a RCC进行开放性部分肾切除术以及对他的低度Ta肾盂UC进行内镜激光消融。 4年后,在严格的监护下,患者身体健康,无病。因此,在适当选择的患者的同一肾脏中,将部分肾切除术用于RCC和内窥镜治疗UC相结合似乎是合理的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号